Aurobindo Pharma gets U.S. FTC go-ahead to acquire Lannett Company
Aurobindo Pharma secures FTC approval for a $250 million acquisition of Lannett Company, enhancing its U.S. manufacturing capabilities.
22 Jun 05:22 · The Hindu
Aurobindo Pharma gets U.S. FTC go-ahead to acquire Lannett Company
Aurobindo Pharma secures FTC approval for a $250 million acquisition of Lannett Company, enhancing its U.S. manufacturing capabilities.
22 Jun 05:22 · The Hindu
last updated on 22 Jun 07:15